MCX stock rises 1.5% ahead of Aug 4 Q1 FY27 results

Stock price action and latest tick

Multi Commodity Exchange of India (MCX) was trading 1.47% higher at ₹2,785.35, compared with its previous close of ₹2,744.90. The price point in the feed was time-stamped Thu Jul 09 2026 10:14:26. Separately, the snapshot also listed a price of ₹2,891, indicating multiple price references in the provided data. The move placed MCX among the stronger names mentioned alongside listed peers in the broader market snapshot. HDFC Asset Management Company was shown up 2.78%, Nippon Life India Asset Management up 3.95%, and Motilal Oswal Financial Services up 3.63%.

What investors are watching: Q1 FY27 review date

MCX is reportedly scheduled to review its standalone and consolidated financial results for the first quarter ended June 30, 2026, on August 4, 2026. The same source note flagged that this date is “as stated in the source alert; not independently verified,” and the timing remains to be officially confirmed. Even so, the date is being tracked as a near-term event risk because the exchange is coming off an unusually strong finish to FY26. The update also described the near-term trading bias as neutral ahead of the Q1 FY27 results (again, per the source alert and not independently verified).

Street positioning: ratings and visible valuation indicators

The provided data indicates that 1 analyst has given the stock a sell rating. On valuation metrics included in the snapshot, MCX was shown with a P/E ratio of 64.9. The market capitalisation was reported at ₹86.5K crore, which corresponds to about ₹86,500 crore. These indicators frame how the market is currently pricing MCX relative to its recent profit surge, and they provide context for how sensitive the stock could be to quarterly swings.

The backdrop: MCX’s “blockbuster” Q4 FY26

MCX entered the current earnings season after a sharp year-on-year jump in Q4 FY26. The exchange reported consolidated revenue from operations of ₹889 crore for the fourth quarter of FY26, described as about 205% higher than the corresponding quarter of the previous year. Consolidated Profit After Tax (PAT) reached about ₹530 crore in Q4 FY26, described as roughly 291% year-on-year growth. Consolidated EBITDA in Q4 FY26 was reported at about ₹703 crore, up around 271% year-on-year.

The longer FY26 numbers in the feed also pointed to broad-based strength across the year. Revenue from operations for FY26 was reported at ₹2,302 crore versus ₹1,113 crore in FY25, a 107% year-on-year increase. Total income for FY26 was reported at ₹2,429 crore versus ₹1,209 crore in FY25, up 101% year-on-year. FY26 EBITDA was reported at ₹1,774 crore versus ₹762 crore in FY25, along with an EBITDA margin of 73%.

Quarterly progression through FY26 (as provided)

Beyond Q4, the dataset included snapshots for earlier quarters. For Q3 FY26, revenue from operations was reported at ₹666 crore, EBITDA at ₹527 crore, and PAT at ₹401 crore. For Q2 FY26, revenue from operations was reported at ₹374.23 crore, EBITDA at ₹270.19 crore, and PAT at ₹197.47 crore. For Q1 FY26, revenue from operations was reported at ₹373.21 crore, EBITDA at ₹274.27 crore, and PAT at ₹203.19 crore.

The data also included average daily turnover (ADT) figures for certain quarters. In Q1 FY26, ADT was reported at ₹3,10,775 crore, with the note attributing the rise to renewed participant interest and a dynamic market environment. For Q2 FY26, ADT was reported at ₹4,11,270 crore. For Q3 FY26, ADT for F&O was reported at ₹7,50,136 crore.

Key financial data table

Market impact: what the numbers imply for expectations

The immediate market relevance of MCX’s Q4 FY26 print is that it sets a high base for comparisons, particularly on profitability. With Q4 FY26 PAT reported at about ₹530 crore, even normal quarter-to-quarter variability can look sharp in percentage terms. The feed also explicitly noted that quarter-to-quarter jumps may show cyclicity due to macro factors, even as the company expects a strong year ahead with continued growth in sales, revenue, and volumes.

The absence of fundraising commentary in the provided earnings call transcript summary also matters for market reading. The same dataset stated there was no explicit mention of current or immediate plans for fundraising through debt or equity, and no specific debt or equity issuance was announced or indicated during the call. For investors, that keeps the focus on operating performance and volumes, rather than capital structure changes.

Consensus watch: Uniresearch projection for Q1 FY27

The dataset included a projection attributed to Uniresearch based on an 11-analyst FY27 consensus. It projected Q1 FY27 revenue at ₹503 crore and PAT at ₹281 crore, referencing a comparison to Q1 FY26 actuals (revenue ₹373 crore and PAT ₹203 crore in the table). The same block mentioned an average analyst target of ₹3,497 on a 12-month view, attributed to 11 analysts. These are projections and targets, not outcomes, and the dataset itself noted such outcomes are not guaranteed.

Analysis: why the Aug 4 event matters

If the August 4, 2026 review proceeds as referenced, it becomes the first formal checkpoint after a year where FY26 revenue from operations reached ₹2,302 crore and FY26 PAT reached ₹1,332 crore. It also follows a period where Q3 FY26 revenue from operations was reported at ₹666 crore and then rose to ₹889 crore in Q4 FY26. Against that backdrop, the market’s attention typically shifts to two areas that are visible in the provided numbers: sustainability of operating leverage (EBITDA reported at ₹703 crore in Q4 FY26) and the stability of participation/volumes (with ADT data rising across earlier quarters as provided).

At the same time, the snapshot valuation data (P/E 64.9) and the presence of at least one sell rating indicate that expectations are not one-way. With such a strong FY26 finish, the market often becomes more sensitive to normalisation, cyclicality, and quarter-to-quarter variance, which the dataset itself flagged as a possibility.

Conclusion

MCX was trading 1.47% higher at ₹2,785.35 as of the provided timestamp, with investors tracking a reportedly scheduled Aug 4, 2026 review of Q1 FY27 results (not independently verified). The upcoming update is being watched closely after Q4 FY26 revenue from operations of ₹889 crore and PAT of about ₹530 crore, alongside FY26 revenue from operations of ₹2,302 crore and PAT of ₹1,332 crore. The next key step, based on the same source note, is confirmation of the Q1 FY27 results review date and the subsequent financial disclosures.